Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib vs placebo in alveolar soft part sarcoma (CASPS)
2010-021163-33Phase 2Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alveolar soft part sarcoma (ASPS) comparing Cediranib with Placebo (2 arms). Primary endpoint: Change in tumor size at week 24. Status: unknown.
02
Drugs
cediranib
03
Conditions
alveolar soft part sarcoma (ASPS)
Beyond the preview
Go deeper on 2010-021163-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021163-33.